DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» GAVI
GAVI
Gavi's Vaccine Investment Strategy
Yellow Fever 2016
Hanna Nohynek @Hnohynek
UNEP Mercury Treaty Protects Access to Thiomersal-Containing Vaccines
Cheat Sheet: COVID-19 Vaccine Pipeline
Yellow Fever Vaccine
An Overview of COVID Vaccine Clinical Trial Results & Some Challenges
Human Papillomavirus Vaccine
'Astrazeneca' Covid-19 Vaccine
GAVI HPV Vaccine Infographic Pdf, 765Kb
Gavi's Vaccine Investment Strategy
The GAVI Alliance
Shaping the Market: Gavi's Model for Bringing the Power of Vaccines To
Final Evaluation of Gavi Alliance's Support to Bosnia and Herzegovina
National Deployment & Vaccination Plan
COVID-19 Vaccines: Rapid Development, Implications
Covaxeurope Put to the Test of Global Vaccine Solidarity
Global Market Study Hpv
Top View
Covid-19: 237M Vaccine Doses to Be Distributed Worldwide
3Rd Global Vaccine Congress
'Vero Cell' COVID-19 Vaccine Rollout in Nepal: What We Know About The
Gavi Alliance Update
HEALTH Aidin TRANSITION
COVID-19 Vaccines: Frequently Asked Questions
ALLOCATION ROUND 3: Pfizer-Biontech Vaccine, April – June 2021
Role of Global Fund and GAVI in COVID-19 Response GAVI
Global Immunization and Gavi Five Priorities for the Next Five Years Center for Global Development
Training on Pfizer-Biontech COVID-19 Mrna Vaccine COMIRNATY® (Tozinameran)
Strategies for HPV Vaccination in the Developing World
Vaccine Innovation Lexicon
COVID-19 Vaccine Development
Gavi, the Vaccine Alliance
The GAVI Alliance
Update on COVID-19 Vaccines Development and Approvals Last Updated: 22Nd February, 2021
Seasonal Influenza Vaccine: Supply Update September 2020
Implementation Strategy and Cost of Mozambique's HPV Vaccine
The Covax Facility: Interim Distribution Forecast—Latest As of 3 February 2021
Considerations for Primary Container Decisions: DCVMN Perspective
Gavi Update: OCV Support and Vaccine Investment Strategy
Guide on Access to the Yellow Fever ICG Stockpile Emergency Campaigns
The Impact of COVID-19 on South Asian Economies by Uzair Younus
Experimental Evidence on Country Immunisation Rates and Child Mortality
Global Vaccination: Trends and U.S
SARS-Cov-2 Neutralizing Antibodies: a Network Meta-Analysis Across Vaccines
Strengthening Immunisation Systems and Introduction of Hepatitis B Vaccine in Central and Eastern Europe and the Newly Independent States
Securing Trust in the Global COVID-19 Supply Chain Securing Trust in the Global COVID-19 Supply Chain
Immune Response After Vaccination Against SARS-Cov-2 Infections
Position Specification
Global Action Plan for Influenza Vaccines 2006–2016
UNICEF's Engagement with Gavi, the Vaccine Alliance
The Potential of Dose-Sparing to Increase Vaccine Supply and Availability
Assessing the Impact of Preventive Mass Vaccination Campaigns on Yellow Fever Outbreaks in Africa : a Population-Level Self-Controlled Case-Series Study
COVID-19 Vaccines By: Richard Jefferys, Treatment Action Group
Gavi Fully Self-Financing & Accelerated Transition Countries
Target Product Profile Analysis of COVID-19 Vaccines in Phase III
Gavi Factsheet
Use of Gavi Support to Maintain, Restore and Strengthen Immunisation in the Context of COVID-19
Report from Gavi
Yellow Fever: a Major Public Health Concern
Pfizer and Biontech Reach Agreement with COVAX for Advance Purchase of Vaccine to Help Combat COVID-19
PR Vaccination GAVI
Human Papillomavirus Vaccine: Supply and Demand Update
Study of Awareness Regarding Covid-19 Vaccines Among General Population
Frequently Asked Questions About COVID-19 Vaccines
Immunization Focus
Vaccines in Africa Memo Vol.1 No.1 Issued: May 3 2021 Brief
PATH Supports Global HPV Vaccine Introduction
The UK's Work with Gavi, the Vaccine Alliance
Yellow Fever Initiative Providing an Opportunity of a Lifetime
The Great Vaccine Robbery
USAID's Investment to Gavi, the Vaccine Alliance
Pakistan Receives First Consignment of COVID-19 Vaccines Via COVAX Facility
Global Justice and the Proposed Ban on Thimerosal-Containing Vaccines
Going for Goal Immunisation and the Case for GAVI Table of Contents
Presentation by Alicia Bárcena, Executive Secretary of ECLAC
Summary of Recommendations Overview of Gavi Full Country
E-Newsletter on COVID-19 Contents……
Covid-19: Where Are We on Vaccines and Variants?
A Summary of the SARS-Cov-2 Vaccines and Technologies Available Or Under Development
Download (357.8
Antibody and T Cell Responses to Sinopharm/BBIBP-Corv in Naïve
Outcomes of 3-4 April WHO Informal Consultation on Vaccines in Preparation for Global Mercury Treaty Dr Elwyn Griffiths and WHO Secretariat 12 April 2012
Protecting Global Access to Lifesaving Vaccines PATH’S Global Advocacy Strategy During the United Nations Environment Program Mercury Treaty Negotiations
Gavi Yellow Fever Diagnostic Initiative
GAVI HPV Vaccine Infographic